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Cardiac Function in End-Stage DCM
A Study Using Speckle Tracking Echocardiography
Andrea M. Cordero-Reyes, MD, Keith Youker, PHD, Jerry D. Estep, MD,
Guillermo Torre-Amione, MD, PHD, Sherif F. Nagueh, MD
Houston, TexasOBJECTIVES We sought to compare the effects of interstitial ﬁbrosis and myocardial force genera-
tion/relaxation elements on left ventricular (LV) function in patients with end-stage dilated cardiomyop-
athy (DCM).
BACKGROUND Interstitial ﬁbrosis is common in patients with advanced heart failure. However,
the extent to which it affects cardiac function remains unclear.
METHODS Longitudinal, radial, and circumferential strain; strain rate during systole (SRS) and strain
rate during early diastole (SRE); LV volume; LV ejection fraction; mean pulmonary capillary wedge pres-
sure (PCWP); and e0 were measured in 20 DCM patients. Myocyte diameter, interstitial ﬁbrosis, messenger
ribonucleic acid (mRNA) levels of molecules implicated in ﬁbrosis and function (transforming growth
factor beta, titin [TTN] N2B and N2BA isoforms, collagen type I, collagen type III, sarcoplasmic reticulum
Ca2þ-ATPase [SERCA2a], phospholamban [PLB], and protein levels of SERCA2a, phosphorylated PLB, and
Smad2/3) were correlated with strain from 4 regions per patient (LV apex, midlateral, septum, and right
ventricular free wall) as well as LV global function. In another group of 8 DCM patients, we evaluated
LV structure and function before and after LV assist device.
RESULTS Signiﬁcant correlations were present among ejection fraction, e0 velocity, PCWP, LV
end-diastolic volume/PCWP ratio, strain, SRS, SRE, and mRNA expression of TTN N2B, N2BA, SERCA2a,
PLB, and protein levels of SERCA2a and phosphorylated PLB (r ¼ 0.53 to 0.95, p < 0.05). Weak to no
associations were present between strain and interstitial ﬁbrosis and its molecular determinants. In
patients with repeat studies, regional strain and SRE best tracked the changes in mRNA expression of
TTN isoform N2BA and mRNA and protein expression of SERCA2a.
CONCLUSIONS LV systolic and diastolic functions in DCM are primarily associated with myocardial
force generation/relaxation elements. (J Am Coll Cardiol Img 2014;7:441–52) ª 2014 by the American
College of Cardiology FoundationFrom the Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, Texas. The authors have reported
that they have no relationships relevant to the contents of this paper to disclose.
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442nterstitial ﬁbrosis is a common ﬁnding in patients (RV) free wall at the time of transplantation. Car-
with dilated cardiomyopathy (DCM) and can
play an important role in affecting left ventricular
(LV) function in these patients (1,2). However, a
recent study has not shown a signiﬁcant association
between replacement ﬁbrosis (as assessed by cardiac
magnetic resonance) in DCM patients and LV
diastolic function (3). Of note, the study did not
evaluate interstitial ﬁbrosis and did not examine
cardiac mechanics (3). We therefore sought to
evaluate the effects of interstitial ﬁbrosis on cardiacnce
II
athy
-
ry
te
the
d
stole
hfunction in DCM patients and determine
the extent to which its effects on cardiac
function dominate over those of sarco-
meric and sarcoplasmic proteins. We ob-
tained cardiac tissue to measure ﬁbrosis in
addition to molecules that determine the
development of ﬁbrosis such as trans-
forming growth factor beta-1 (TGFb1)
and its downstream mediators: phosphor-
ylated Smad2/3 (1). Given the effects of
calcium cycling proteins and titin (TTN)
on LV systolic and diastolic function, we
selected these molecules to determine
their contributions in these patients. For
calcium-cycling proteins, several studies
have shown a signiﬁcant relation between
the protein levels of sarcoplasmic reticulum
Ca2þ-ATPase (SERCA2a), sarcoplasmic
reticulum calcium uptake, and the force
frequency relationship in patients with
heart failure (4,5). For TTN isoforms, a
number of previous reports showed the
important role that this molecule plays in
determining LV diastolic stiffness (6).
These relationships are of potential clinical
interest, as changes in the level of these
proteins or their phosphorylation status can
be used to improve LV function in patients
with end-stage heart failure.
METHODSPatient population. The study sample included 20
heart failure patients with DCM who underwent
cardiac transplantation in the previous 2 years. The
patients were on contemporary medical therapy for
systolic heart failure including cardiac resynchroni-
zation therapy in 13 patients. Clinical, echocardio-
graphic, and invasive hemodynamic evaluations
were performed within 20 to 60 days of trans-
plantation. Full-thickness specimens of the LV
apex, midseptum, and midlateral walls were removed
from explanted hearts as well as the right ventriculardiac tissue was obtained from the hearts of 4 donors
without cardiac disease who died of head injuries or
bleeding (mean age 32  8 years; LV ejection
fraction [EF] 60  4%).
To help evaluate the underlying mechanisms
behind the change in cardiac function, we sought to
compare the changes in cardiac pathology and
messenger ribonucleic acid (mRNA) and protein
expression with the changes in cardiac function in a
setting that leads to reverse remodeling. To achieve
this objective, we included 8 patients with a wide
duration range of left ventricular assist device
(LVAD) support who had the device implanted as a
bridge to cardiac transplantation. These 8 patients
had cardiac imaging on 2 occasions: just before
LVAD implantation and just before cardiac trans-
plantation. The duration of LVAD support varied
from 32 to 1,402 days. Changes in segmental
function of the distal 1-cm region of the lateral wall
were related to tissue analysis results.
Echocardiographic imaging. A complete echocar-
diographic study was performed according to stan-
dard views (parasternal and apical views) and
guidelines (7–9). Care was taken to obtain 3 para-
sternal circular short-axis tomograms: basal (iden-
tiﬁed by the mitral valve), papillary, and apical (no
papillary muscles noted) levels. Two-dimensional
image acquisition was carried out at a frame rate
of 40 to 50 frames/s, and 3 cardiac cycles were
stored in cine loop format. The study was stored
digitally for ofﬂine analysis.
Echocardiographic analysis. Echocardiographic mea-
surements were performed by an observer without
knowledge of histopathology and molecular ﬁndings.
LV volumes, EF, left atrial volume, and Doppler
velocities and ratios were measured per American
Society of Echocardiography guidelines (7,8). Defor-
mation analysis was performed using a commercially
available system (syngo Velocity Vector Imaging,
Siemens Healthcare, Malvern, Pennsylvania) (10).
Adequate tracking was veriﬁed in real time and cor-
rected, if necessary. Longitudinal strain and strain
rates (SR) (strain rate during systole [SRS], strain rate
during early diastole [SRE], and strain rate during late
diastole [SRA]) were measured from the apical views.
Circumferential strain and radial strain (and SR) were
measured from the short-axis views (9). Global SR
during the isovolumic relaxation period (SRIVR) and
SRE were measured, and the ratios of E/SRIVR and
E/SRE were derived (9). Mean interobserver differ-
ence for the different strain and SR measurements
varied from 3.0% to 2.5% (SD: 0.5% to 2.0%).
Mean intraobserver difference ranged from 2%
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443to 2% (SD: 0.6% to 1.5%). Apical untwisting ve-
locity was measured and used for analysis of the
molecular and cellular determinants of untwisting at
that level. The segmentation used is the standard
segmentation with the following segments: basal,
mid, and distal anterior wall; basal, mid, and distal
inferior wall; basal, mid, and distal lateral wall; basal,
mid, and distal septum; base and midposterior (or
inferolateral) wall; LV apex; and RV free wall (9).
This same segmentation was used for molecular and
histopathological analysis.
Myocardial tissue analysis. Tissue was procured
under an approved institutional review board pro-
tocol. Tissue samples were cut from each region into
3 adjacent portions: 2 were immediately snap-frozen
and used for polymerase chain reaction and protein
studies, and 1 portion was ﬁxed in 2% para-
formaldehyde, processed, parafﬁn-embedded, and
cut into 5-mm sections. To measure ﬁbrosis, sec-
tions were stained with Masson’s trichrome stain
(Sigma-Aldrich, St. Louis, Missouri). The slides
were then cover-slipped and analyzed at 20
magniﬁcation using an Olympus AX70 microscope
(Olympus Corporation, Tokyo, Japan). Five repre-
sentative pictures were taken from each slide and
analyzed for ﬁbrosis using Image Pro Plus version
4.0 analysis software (Media Cybernetics, Silver
Spring, Maryland). A color cube–based selection
criterion was used to denote positive staining, and
stained/unstained areas were measured. The results
expressed are the average percentage of tissue area
(pixels) stained by the blue dye. Analysis was per-
formed by an observer blinded to the sample iden-
tities. Myocyte diameter was measured at the level
of the nucleus in hematoxylin-eosin–stained sec-
tions. At 20 magniﬁcation ﬁelds, a point-to-point
perpendicular line drawn across the cross-sectional
area of the myocytes at the level of the nucleus
and the diameter length was measured with the
computer imaging software. A total of 50 myocytes/
slide were measured from each tissue specimen, and
the mean  SD per section were noted (11).
Analysis of gene expression. Total mRNA was
isolated from cardiac tissues using ribonucleic acid
(RNA)-binding columns (RNaqueous-4-polymerase
chain reaction, Ambion, Life Technologies, Grand
Island, New York). RNA was immediately reverse-
transcribed into complementary deoxyribonucleic
acid with a kit using random primers (iScript,
Bio-Rad, Hercules, California) according to
the manufacturers’ directions. Real-time reaction
mixtures contained 11 ml of H2O, 12 ml of IQ
SYBR Green Supermix (Bio-Rad), 1 ml of primers,
and 1 ml of complementary deoxyribonucleic acidtemplate (25 ml total). Sense and antisense primers
were chosen from the RTPrimerDB public primer
database for humans. Reactions were aliquoted into
96-well plates and plates were sealed, centrifuged at
500 g for 60 s, and ampliﬁed for 40 cycles of 10 s
at 95C, 30 s at 55C, and 10 s at 72C. Real-
time polymerase chain reactions were analyzed in a
MyIQ5 iCycler (Bio-Rad) in triplicate and
normalized to glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), a housekeeping gene run on
the same plate for every sample that was tested (12).
This approach was performed to normalize for
potential differences in the amount of RNA in
different regions. Gene expression levels were
determined for TGFb1, TTN isoforms N2B and
N2BA (13), collagen type I (COLIA1), collagen
type III (COLIIIA1), sarcoplasmic reticulum Ca2þ-
ATPase (SERCA2a), and phospholamban (PLB).
Protein expression analysis. Cardiac tissue was
placed in 10 times its volume of tissue lysis buffer
(Invitrogen, Carlsbad, California) with added pro-
tease inhibitor cocktail (Sigma-Aldrich). Samples
were then homogenized and incubated on ice for 20
min with gentle vortex every 5 min. Samples were
centrifuged at 10,000 g at 4C for 15 min, and the
pellet was discarded and the supernatant was
quantiﬁed for protein using a photometer. Samples
were standardized and solubilized in Laemmli
buffer with B-mercaptoethanol and placed in 80C
water for 5 min. Twenty-ﬁve micrograms of each
sample were blotted on a nylon membrane using an
immune-blot apparatus and antibody stained.
Antibody staining was initiated with blocking for
30 min in a blocking buffer (phosphate-buffered
saline with 1% horse serum), incubation with pri-
mary antibody diluted in blocking buffer for 1 h
and washed. Blots were then incubated for 1 h in
secondary antibody conjugated with alkaline phos-
phatase diluted in blocking buffer, followed by
washing with phosphate-buffered saline. The ﬁnal
step for color development used was NBT/BCIP
(Thermo Scientiﬁc, Waltham, Massachusetts) as a
substrate for 15 to 20 min. Staining intensity was
measured by densitometric analysis with the Image
Pro Plus software. Protein expression levels were
determined for SERCA2a, phosphorylated PLB,
and phosphorylated Smad2/3 (all antibodies from
Santa Cruz Biotechnology, Santa Cruz, California).
Statistics. Data are presented as mean  SD or
median (25th to 75th percentile) where appropriate.
Repeated-measures analysis of variance (ANOVA)
and 1-way ANOVA on ranks were used to compare
the structural and functional parameters between
the different segments in patients. Subsequent
Table 1.
Heart rate
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Pulmonar
Pulmonar
Mean righ
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Cardiac in
Left ventr
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444pairwise multiple comparison procedures were per-
formed using the Dunn or Holm-Sidak method.
Patients and control subjects were compared using
an unpaired Student t test or rank sum test based on
data distribution. Regression analysis (linear and
nonlinear) was used to relate the extent of collagen,
myocyte size, and gene/protein expression to systolic
and diastolic function (1 region/patient and thus
using patients as the units of analysis). Measure-
ment variability was determined by repeated mea-
surements from 6 studies at 2 time points 3 weeks
apart. The absolute difference was calculated as well
as the mean  SD. A p value <0.05 was used to
deﬁne statistical signiﬁcance.
RESULTS
The group (20 patients; 8 women) had a mean age
of 53  13 years. All patients had advanced heart
failure with a New York Heart Association func-
tional class III to IV. RV function was severely
depressed in 4 patients, moderately depressed in 8
patients, and mildly depressed in 2 patients, and the
rest had normal RV function. Moderate mitral
regurgitation was present in 3 patients, and the rest
had trace to mild lesions. Moderate tricuspid
regurgitation was present in 1 patient, another pa-
tient had severe regurgitation, and the rest had trace
to mild lesions. The echocardiographic and hemo-
dynamic ﬁndings are summarized in Table 1.Summary of Echocardiographic and Hemodynamic Measurements
, beats/min 80.0  3.0
lood pressure, mm Hg 106.0  4.0
lood pressure, mm Hg 64.0  3.0
y artery systolic pressure, mm Hg 50.0  5.0
y artery diastolic pressure, mm Hg 29.0  3.0
t atrial pressure, mm Hg 13.0  1.4
monary capillary wedge pressure, mm Hg 21.0  2.0
dex, l/min/m2 1.9  0.1
icular end-diastolic volume index, ml/m2 111.0  9.0
icular end-systolic volume index, ml/m2 82.0  10.0
raction, % 30.0  3.5
maximal volume index, ml/m2 47.0  4.0
ratio 2.4  0.4
ion time of mitral E velocity, ms 151.0  18.0
0 velocity, cm/s 5.7  0.5
/e0 ratio 16.0  2.0
0 velocity, cm/s 5.6  0.9
onsumption, ml/kg/min 9.3  1.5
mean  SD.Interstitial ﬁbrosis and myocyte size. Table 2 pre-
sents a summary of the ﬁndings for the 4 regions.
Signiﬁcant differences were noted for the percentage
of ﬁbrosis between mid-RV free wall and LV
segments (p < 0.05 vs. all 3 LV regions). Likewise,
myocyte diameter was smaller for RV myocytes
versus LV myocytes, albeit with some overlap
(p < 0.05 vs. LV midlateral wall) (Fig. 1).
mRNA levels of selected molecules involved in myocar-
dial dysfunction and interstitial ﬁbrosis in patients and
comparison with normal control subjects. There was
evidence of up-regulation of mRNA levels of several
genes when patients were compared with control
subjects: TGFb1, TTN N2BA isoform (non-
normal distribution), COLIA1, COLIIIA1, and
PLB (all p values <0.01). However, mRNA levels
of SERCA2a were lower in patients compared with
control subjects (p < 0.01).
Regional variations were present for the mRNA
levels of COLIA1, COLIIIA1, and TGF-b. TGF-b
and COLIA1 mRNA levels among different LV
regions were signiﬁcantly correlated (using individ-
ual patients as the units of analysis: r ¼ 0.45 to 0.8,
p < 0.05).
Protein expression. SERCA2a protein levels were
signiﬁcantly lower in patients versus control subjects
(p < 0.01). However, phosphorylated PLB and
phosphorylated Smad2/3 protein levels were
signiﬁcantly higher in patients versus control sub-
jects (both p < 0.05).
The regional protein expression of SERCA2a
was similar to its gene expression, with a signiﬁcant
relationship noted in the 4 sampled regions (r ¼
0.48 to 0.63, p < 0.05). Regional protein expression
of phosphorylated PLB was related to its gene
expression with a signiﬁcant relationship noted in
the 4 sampled regions (r ¼ 0.74 to 0.88, p < 0.01).
Similarly, phosphorylated Smad2/3 and TGFb1
gene expression were signiﬁcantly correlated (r ¼
0.85 to 0.94, p < 0.01).
Myocyte size and interstitial ﬁbrosis and segmental
function. Systolic and diastolic functions were
depressed in the apex, lateral, septal, and RV lateral
wall segments, as reﬂected by the reduced longitu-
dinal, radial, and circumferential strain, SRS and
SRE (Table 2). Signiﬁcant associations between SRS
and strain, as well as SRE, and each of strain and
SRS were observed for all 4 regions (r ¼ 0.6 to 0.94,
p < 0.05).
An inverse relationship between the extent of
interstitial ﬁbrosis and segmental systolic function
was present but it did not reach the statistical sig-
niﬁcance level (the best relationship was present for
apical longitudinal SRS with r ¼ 0.47, p ¼ 0.09).
Table 2. Histopathology and Myocardial Strain/SRS and SRE in the Left and Right Ventricle
LV Apex Midlateral Midseptum RV Free Wall
Fibrosis, % 26.0  5.6 26.7  4.8 30  5.5 10.0  2.0*
Myocyte diameter, mm 68.0  3.9 76.0  3.8 66.0  3.0 61.0  2.7y
Longitudinal strain, % 4.3 (5.6 to 2.8)y 6.0 (9.2 to 4.2) 3.0 (4.8 to 1.5)y 5.6 (7.6 to 2.8)
Longitudinal SRE, s
1 0.10 (0.06 to 0.14)y 0.19 (0.13 to 0.29) 0.10 (0.05 to 0.19)y 0.16 (0.08 to 0.26)
Circumferential strain, % 4.2 (6.2 to 1.45)y 7.5 (10.4 to 4.4) 4.4 (6.8 to 2.1)y 3.5 (4.8 to 1.75)y
Circumferential SRE, s
1 0.1 (0.06 to 0.17)y 0.18 (0.10 to 0.24) 0.12 (0.08 to 0.17)y 0.12 (0.04 to 0.18)y
Radial strain, % 11.4 (7.3 to 21.5)y 21.0 (10.3 to 30.6) 10.6 (4.2 to 17.0)y 13.3 (7.2 to 23.0)y
Radial SRE, s
1 0.29 (0.7 to 0.14)y 0.8 (1.4 to 0.46) 0.37 (0.75 to 0.15)y 0.32 (0.89 to 0.27)y
Values are mean  SD or median (25th to 75th percentile). *p < 0.05 versus 3 other groups. yp < 0.05 versus midlateral wall.
LV ¼ left ventricular; RV ¼ right ventricular; SRE ¼ strain rate during early diastole; SRS ¼ strain rate during systole.
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445However, signiﬁcant correlations were observed
between myocyte diameter and strain, SRS, and
SRE (for longitudinal and circumferential strain and
SRS [r ¼ 0.52 to 0.76], for longitudinal and cir-
cumferential SRE [r ¼ 0.65 to 0.78, p < 0.05],
all p values <0.05) (Fig. 2) such that segments with
a larger myocyte diameter had less deformation.
mRNA expression of COLIA1, COLIIIA1, TGFb1, and
phosphorylated Smad and segmental function. No
signiﬁcant associations were noted between strain
and SRS measurements and mRNA expression ofFigure 1. Fibrosis Deposition With Trichrome Stain and Myocyte Si
(A) Lower amount of deposition in the right ventricular free wall of pa
the same patient. Myocyte size in patient A is also smaller in the right
(D). Magniﬁcation 20.TGFb1, COLIA1, COLIIIA1, and phosphory-
lated Smad2/3.
Similarly, there were no signiﬁcant correlations
with SRE except for septal longitudinal SRE in
which weak associations were noted with mRNA
expression of COLIA1 and phosphorylated Smad2/3
(r ¼ 0.45 to 0.5, p ¼ 0.05).
mRNA and protein expression of SERCA2a and PLB
and segmental function. Strain and SRS were related
to mRNA expression of SERCA2a, SERCA2a/PLB
ratio, and protein expression of SERCA2a andze From a Hematoxylin and Eosin Stain
tient A. (B) Increased ﬁbrosis in the left ventricular free wall in
ventricular free wall (C) than in the left ventricular free wall
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446phosphorylated PLB. More deformation was noted
in segments with higher SERCA2a (mRNA and
protein) content (apex, r ¼ 0.5 for radial strain
to 0.83 for longitudinal strain; lateral wall,
r ¼ 0.55 for circumferential SRS to 0.82 for
longitudinal strain; septum, r ¼ 0.53 for longitu-
dinal strain to 0.6 for circumferential strain; RV,
r ¼ 0.56 to 0.65; all p values <0.05) (Fig. 3).
Diastolic function was also better for segments
with higher SERCA2a (mRNA and protein) content
and higher phosphorylated PLB protein content
(apex, r ¼ 0.5 to 0.65; lateral wall, r ¼ 0.55 to 0.61;
septum, r ¼ 0.5 to 0.68; RV, r ¼ 0.52 to 0.66; all p
values <0.05). The results were largely unchanged
when the ratio of the molecules to GAPDH was used
(for systolic parameters, r ¼ 0.5 to 0.84; for di-
astolic parameters, r ¼ 0.53 to 0.73; all p values
<0.05).
mRNA expression of TTN N2B and N2BA and
segmental function. Strong correlations were
observed between circumferential and longitudinal
SRE and mRNA expression of TTN N2B and
N2BA isoforms and their ratio (apex, r ¼ 0.65
to 0.93; lateral, r ¼ 0.78 to 0.87; septal, r ¼ 0.63
to0.67; RV, r ¼ 0.62 to0.71; all p values <0.05)
(Fig. 4). The results remained signiﬁcant when the
ratio of TTN mRNA molecules to GAPDH was
used (r ¼ 0.79 to 0.94; all p values <0.05).
mRNA and protein expression and LV global
function. To examine the determinants of global LV
function, the average values of mRNA expression
and protein expression in the 3 LV regions were used.
LV volumes and EF were not related to interstitialFigure 2. Myocyte Diameter and Segmental Strain and Early Diasto
Relationship between myocyte diameter and longitudinal strain for late
the right (linear regression). SRE ¼ strain rate during early diastole.ﬁbrosis or its molecular determinants. However, they
were related to myocyte diameter such that larger
ventricles (both end-diastolic and -systolic volumes)
and lower EF were associated with larger myocytes
(end-diastolic volume, r ¼ 0.56; end-systolic volume,
0.64; EF, 0.79; p < 0.05). Likewise, signiﬁcant
associations were present between global longitudinal
strain and each of the following: myocyte size, inter-
stitial ﬁbrosis, and mRNA SERCA2a/PLB ratio
(r ¼ 0.58 to 0.73; all p values <0.05).
For LV diastolic function, we examined the de-
terminants of relaxation and stiffness. For relaxa-
tion, the mRNA and protein expression levels of
SERCA2A related well to average early diastolic
annular velocity (e0), SRIVR, and SRE (Fig. 5). For
stiffness, the ratio of mRNA expression of TTN
N2BA to N2B isoforms decreased from grade I
to grade III diastolic dysfunction (ANOVA, p ¼
0.013) and was related to E/e0, E/SRIVR, and
E/SRE (r ¼ 0.6 to 0.68, p < 0.05) as well as LV
EDV/pulmonary capillary wedge pressure (PCWP)
ratio (r ¼ 0.68, p < 0.05).
In comparison, there was no signiﬁcant rela-
tionship between the different parameters of LV
global diastolic function and ﬁbrosis (best relation-
ship noted was between mean PCWP and mRNA
expression of COLIA1 [r ¼ 0.41, p ¼ 0.11]).
Determinants of apical untwisting velocity. Apical
untwisting velocity was related to the twisting ve-
locity (r ¼ 0.7, p < 0.05). Aside from this rela-
tionship, the strongest signiﬁcant determinant of
the untwisting velocity was the mRNA expression
level of TTN N2B (Fig. 6).lic Strain Rate From 2 Left Ventricular Regions
ral wall segments to the left and longitudinal septal SRE to
Figure 3. SERCA2a Protein Expression Level and Lateral
Longitudinal Strain
Relationship between SERCA2a protein expression level (DCM/
control) and lateral longitudinal strain (linear regression).
DCM ¼ dilated cardiomyopathy; SERCA2a ¼ sarcoplasmic
reticulum Ca2þ-ATPase.
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447Cardiac function, mRNA, and protein expression
before and after LVAD support. With LVAD sup-
port, the group of 8 patients (48  11 years of age;Figure 4. TTN N2B and N2BA mRNA Expression Level and Lateral W
(Left) Relationship between mRNA expression level of TTN N2BA (DCM/
bx2) and lateral circumferential SRE. (Right) Relationship between mRN
SRE (inverse ﬁrst-order equation of y ¼ y0 þ a/x). mRNA ¼ messenger ri2 females) showed a signiﬁcant decrease in LV
and left atrial volumes, with an increase in LVEF
(p < 0.05), but smaller changes in global strain
parameters (Table 3). Overall, improvement was
noted in segmental strain and SRE (Table 4). The
percentage of changes was used in the analysis so
each patient would serve as his or her control.
There was a wide range of changes in cardiac
pathology and mRNA and protein changes in the 8
patients. The magnitude and direction of changes in
mRNA and protein levels of SERCA2a were
similar (r ¼ 0.78, p ¼ 0.02). Likewise the changes
in mRNA and protein levels of PLB were correlated
(r ¼ 0.8, p ¼ 0.02). Although mRNA levels of
COLIA1 and COLIIIA1 decreased, the change in
ﬁbrosis and myocyte diameter did not reach the
signiﬁcance level.
With respect to the structure-function relation-
ship, there were no signiﬁcant correlations between
changes in ﬁbrosis and myocyte size and changes in
segmental systolic and diastolic function (r ¼ 0.1 to
0.2, all p values >0.6). In comparison, the changes
in mRNA and protein levels of SERCA2a related
well with the changes in longitudinal (r ¼ 0.73, p ¼
0.03) and circumferential strain (Fig. 7) such that
the increase in SERCA2a protein levels was
accompanied by more longitudinal and circumfer-
ential compression (more negative strain). For radial
strain, the association was of borderline signiﬁcance
(p ¼ 0.08). Longitudinal and circumferential SRE
appeared to track the changes in mRNA expressionall Early Diastolic Strain Rate
control) in lateral wall segments (quadratic equation of y ¼ y0 þ ax þ
A expression level of TTN N2B (DCM/control) and lateral longitudinal
bonucleic acid; TTN ¼ titin; other abbreviations as in Figures 2 and 3.
Figure 5. SERCA2a mRNA Expression, Protein Expression, and Average e’ Velocity
Relationship between mRNA expression level of SERCA2a and average e0 (left) and between SERCA2a protein expression level (DCM/control)
and average e0 (linear regression) (right). For 3 patients, e0 was not entered in the regression analysis due to merging of e0 and a0 .
Abbreviations as in Figures 3 and 4.
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448of TTN N2BA such that patients with higher gene
expression levels of the isoform had an increase in
SRE after LVAD support compared with baseline
(Fig. 7). The changes in radial SRE did not reach
the signiﬁcance level (p ¼ 0.09).DISCUSS ION
The results of the current study lend credence to the
notion that a strong predictor of the abnormalFigure 6. TTN N2B mRNA Expression Level and Apical
Untwisting Rate
Relationship between apical untwisting rate and apical mRNA
expression level of TTN N2B (linear regression). LV ¼ left
ventricular; other abbreviations as in Figure 4.cardiac function in patients with DCM lies with
cellular expression of calcium-cycling proteins and
TTN isoforms, although the study cannot prove a
cause-and-effect relationship given its design. The
results were consistent on both the segmental and
global levels. Furthermore, the results were very
similar whether one considers conventional or more
novel indexes of cardiac function. The results with
respect to interstitial ﬁbrosis were weaker in this
population and somewhat different from other dis-
eases in which replacement ﬁbrosis is common as inTable 3. Global Cardiac Function Before LVAD Implantation
and Before Cardiac Transplantation
Before LVAD
Implantation
Before Cardiac
Transplantation
Heart rate, beats/min 91.0  14.0 80.0  9.0
Systolic blood pressure, mm Hg 98.0  13.0 90.0  9.0
LV end-diastolic volume, ml 320.0  48.0 178.0  51.0*
LV end-systolic volume, ml 259.0  43.0 135.0  51.0*
LVEF, % 20.0  2.0 34.0  6.0*
LA maximal volume index, ml 101.0  15.0 57.0  12.0*
Global longitudinal strain, % 4.6  2.0 5.7  1.0
Global SRIVR, s
1 0.06  0.40 0.10  0.05*
Global SRE, s
1 0.23  0.12 0.35  0.20y
Values are mean  SD. *p < 0.05. yp ¼ 0.06.
LA ¼ left atrial; LVAD ¼ left ventricular assist device; LVEF ¼ left ventricular
ejection fraction; SRIVR ¼ strain rate during the isovolumic relaxation period;
other abbreviations as in Table 2.
Table 4. Segmental Function Before LVAD Implantation
and Before Cardiac Transplantation
Before LVAD
Implantation
Before Cardiac
Transplantation
Longitudinal strain, % 2.8  0.8 5.6  1.3*
Longitudinal SRE, s
1 0.21  0.16 0.43  0.29*
Circumferential strain, % 4.7  3.0 6.5  4.0
Circumferential SRE, s
1 0.39  0.40 0.59  0.30*
Radial strain, % 11.5  14.0 17.0  13.0y
Radial SRE, s
1 0.56  0.40 0.82  0.40*
Values are mean  SD. *p < 0.05. yp ¼ 0.08.
Abbreviations as in Tables 2 and 3.
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449post-infarction cardiomyopathy, and its extent can
be used to determine the presence of myocardial
viability (14–16).
Relationship of myocardial structure to function.
Although, in general, larger amounts of interstitial
ﬁbrosis are associated with worse function, the na-
ture and severity of the disease may account for the
different observations in this study. The extent and
pattern of ﬁbrosis in DCM are known to be
different from those seen in patients with coronary
artery disease and post-infarction cardiomyopathy
in which there are large areas of replacement ﬁbrosis.
Interestingly, cellular hypertrophy was associated
with a worse segmental function (systolic and dia-
stolic). This observation is similar to previous studies
(11), and it is likely that cellular hypertrophy occurs
as a compensatory response to segmental dysfunction
and ﬁbrosis. Furthermore, interstitial abnormalitiesFigure 7. Changes in SERCA2a Protein Expression, TTN N2BA mRNA
(Left) Relationship between the change in SERCA2a protein level (post
LVAD). (Right) Relationship between the change mRNA expression leve
LVAD ¼ left ventricular assist device; other abbreviations as in Figuresmay contribute to the wasted contraction and LV
dysfunction in these patients, and it is difﬁcult to
isolate these mechanisms of interaction by imaging.
Collagen, TGF-b, and myocardial function. The
presence of collagen, its isoforms, and the status of
collagen cross-linking all play an important role in
determining myocardial stiffness. Likewise, TGF-b1,
through its downstream mediator phosphorylated
Smad2/3, results in increased matrix production and
reduced collagen degradation and thus increased
interstitial ﬁbrosis (1,17). Although the relationship
between ﬁbrosis and cardiac function in this group
of patients was weaker than other patient groups,
trends were noted with some segmental strain pa-
rameters as well as mean PCWP. Furthermore,
ﬁbrosis was signiﬁcantly related to LV global lon-
gitudinal strain.
The study of the evolution of cardiac structural
and functional changes is better done in animals.
This would allow serial measurements and the
determination of which abnormality occurs earliest
andwhich best tracks the changes in cardiac function.
However, there can be limitations to this approach as
large animal models differ from and may not neces-
sarily have the human pathology. For example,
canine models of pacing-induced heart failure, which
results in DCM, do not show myocyte hypertrophy
and ﬁbrosis. On the other hand, large animal models
with coronary microembolization show the charac-
teristic ﬁndings noted in humans with ischemic
cardiomyopathy including ﬁbrosis and hypertrophy
but also microinfarctions, which are absent in
most patients with isolated DCM (18).Expression With LVAD and Myocardial Function
-/pre-LVAD) versus the change in circumferential strain (pre-/post-
l of TTN N2BA and the change in longitudinal SRE (post-/pre-LVAD).
2 to 4.
Cordero-Reyes et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 5 , 2 0 1 4
Molecular Correlates of Cardiac Mechanics in DCM M A Y 2 0 1 4 : 4 4 1 – 5 2
450TTN isoform expression and myocardial function.
The macromolecule TTN is expressed in 2 isoforms
that affect myocardial stiffness. The 2 forms are
N2B, with a shorter extensible segment compared
with the N2BA isoform, which has longer seg-
ments. The relative expression of the 2 isoforms has
been shown to relate to myocardial and chamber
stiffness in several diseases including patients with
systolic and diastolic heart failure (13,19–21). A
higher amount of N2B isoform is accompanied by
increased myocardial stiffness, whereas greater
N2BA isoform expression can lead to a more
complaint ventricle. In that regard, previous animal
studies have shown an inverse relationship between
segmental SRE and the regional stiffness constant
measured invasively (16). Accordingly, the signiﬁ-
cant correlations between SRE and N2B (negative
correlation) and N2BA (positive correlation) are
consistent with the effects of isoform switching on
LV stiffness. Likewise, the relationship of LV ﬁlling
pattern, LV stiffness surrogate, and the ratio of
mRNA expression of TTN N2BA to N2B are
consistent with the ﬁndings at the segmental level
and the previously referenced studies in humans.
We noted a signiﬁcant association between the
mRNA expression of TTN N2B and apical un-
twisting rate. Previous work in an animal model
with pacing-induced tachycardia showed increased
expression of the more compliant N2BA isoform
in the subendocardium of animals with systolic
dysfunction and reduced restoring forces (22). To
our knowledge, this is the ﬁrst study in humans to
show the strong association between the less
extensible TTN N2B isoform and apical untwisting,
such that higher mRNA levels of this molecule
were accompanied by a higher untwisting rate. The
stronger restoring forces of TTN N2B (vs. TTN
N2BA) leading to faster untwisting likely provide
the mechanistic link for this observation.
SERCA2a, PLB, and myocardial strain. Calcium
transport by the sarcoplasmic reticulum plays a
major role in the regulation of myocyte contractility
and relaxation. In that regard, SERCA2a pump
activity is 1 of the important mechanisms that leads
to lower calcium concentration in the sarcoplasm
and thus results in muscle relaxation. Cardiac
SERCA2a activity is regulated by PLB. Dephos-
phorylated PLB acts as an inhibitor of SERCA2a,
whereas phosphorylation of the PLB molecule re-
lieves SERCA2a of the inhibitory effects and results
in increased calcium transport across the sarco-
plasmic reticulum (23). Our ﬁndings of signiﬁcant
associations between segmental strain, global LV
systolic and diastolic function, and the mRNA andprotein expression of SERCA2a, SERCA2a/PLB
ratio, and phosphorylated PLB are in line with the
cited studies and support the important role of these
molecules in determining cardiac function in pa-
tients with end-stage DCM.
Study limitations. The results presented are based
on data gathered from patients with advanced car-
diac disease. Whether similar relationships occur in
less symptomatic patients is an important question
to address. However, it is challenging to acquire
full-thickness biopsy specimens from multiple LV
regions in patients with earlier stages of cardiac
disease. There was a time lapse between imaging
and obtaining cardiac tissue in the initial group of
20 patients. Therefore, we cannot exclude that
further changes in cardiac pathology could have
occurred between the 2 time points.
We sought to study the changes in cardiac pa-
thology and mRNA and protein expression. This
is ideally done by looking at changes in the same
patient over a number of time points. However, it
is difﬁcult to obtain repeat LV samples from the
same patient. Accordingly, we acquired cardiac
tissue at 2 time points from each patient and ob-
tained a wide range of pathology changes as the
patients had a wide range of LVAD support
duration. The control group was younger than the
patient group, but this was unavoidable as young
individuals are usually the ones selected for donor
hearts.
Other potentially important molecules were not
examined. We sought to evaluate the ones that have
been well characterized and known to affect inter-
stitial ﬁbrosis and myocyte function. Although we
did not evaluate the protein levels or phosphoryla-
tion state of TTN isoforms, which are known to
alter myocardial stiffness (24), our results already
strongly support the important role that this mole-
cule plays in determining regional and global LV
diastolic function. The small sample size may have
precluded us from showing signiﬁcant correlations
between ﬁbrosis and a number of cardiac function
parameters. Nevertheless, the statistical analysis
suggests that the effects of ﬁbrosis on cardiac
function are weaker in this patient group than what
have been reported in other patients.
The frame rate may have led to underestimation
of peak SR measurements. However, we believe
that this is a homogeneous effect that applies to
all acquisitions and is unlikely to have a differential
effect on the results. Invasive measurements of
LV stiffness constant were not performed, and
surrogate noninvasive and invasive parameters were
obtained instead. However, the use of noninvasive
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451imaging is unlikely to have led to different results
because the same surrogate of stiffness was related
to the parameters of interest, namely, ﬁbrosis and
mRNA and protein expression levels of key mole-
cules that determine cellular function. If the
noninvasive parameters were a poor surrogate of
tissue stiffness, one would have seen weak correla-
tions across the board rather than only with ﬁbrosis.CONCLUS IONS
The results of this study support the ongoing efforts
in identifying novel approaches to the treatment of
patients with LV systolic dysfunction. Importantly,increasing the expression of SERCA2a appears to
have a promising role in the treatment of patients
with advanced heart failure (25). Furthermore, given
the strong association between TTN isoforms and
indexes of LV regional and global diastolic function,
LV diastolic performance can be improved in these
patients by increased phosphorylation of TTN by
protein kinase G as well as increasing cyclic gua-
nosine monophosphate levels (24).Reprint requests and correspondence: Dr. Sherif F.
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